Fol. Biol. 2019, 65, 159-169

https://doi.org/10.14712/fb2019065040159

Polymorphisms rs2167444 and rs508384 in the SCD1 Gene Are Linked with High ApoB-48 Levels and Adverse Profile of Cardiometabolic Risk Factors

B. Staňková1, J. Macášek1, M. Zeman1, M. Vecka1, E. Tvrzická1, M. Jáchymová2, A. Slabý1, Aleš Žák1

14th Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic
2Institute of Clinical Chemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic

Received June 2019
Accepted June 2019

References

1. Ahotupa, M., Ruutu, M., Mantyla, E. (1996) Simple methods of quantifying oxidation products and antioxidant potential of low-density lipoproteins. Clin. Biochem. 29, 139-144. <https://doi.org/10.1016/0009-9120(95)02043-8>
2. Alberti, K. G., Zimmet, P., Shaw, J. (2006) Metabolic syndrome – a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet. Med. 23, 469-480. <https://doi.org/10.1111/j.1464-5491.2006.01858.x>
3. Alipour, A., Valdivielso, P., Elte, J. W., Janssen, H. W., Rioja, J., van der Meulen, N., van Mechelen, R., Njo, T. L., González-Santos, P., Rietveld, A. P., Cabezas, M. C. (2012) Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice. Eur. J. Clin. Invest. 42, 702-708. <https://doi.org/10.1111/j.1365-2362.2011.02635.x>
4. ALJohani, A. M., Seyed, D. N., Ntambi, J. M. (2017) Insight into stearoyl-CoA desaturase-1 regulation of systemic metabolism. Trends Endocrinol. Metab. 28, 831-842. <https://doi.org/10.1016/j.tem.2017.10.003>
5. Arregui, M., Buijsse, B., Stefan, N., Corella, D., Fisher, E., di Giuseppe, R., Coltell, O., Knüppel, S., Aleksandrova, K., Joos, H.-G., Boeing, H., Weikert, C. (2012) Heterogeneity of the stearoyl-CoA desaturase-1 (SCD1) gene and metabolic risk factors in the EPIC-Potsdam Study. PLoS One 11, e48338. <https://doi.org/10.1371/journal.pone.0048338>
6. Assies, J., Pouwer, F., Lok, A., Mocking, R. J., Bockting, C. L., Visser, I., Abeling, N. G., Duran, M., Schene, A. H. (2010) Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS One 5, e10635. <https://doi.org/10.1371/journal.pone.0010635>
7. Byberg, L., Kilander, L., Warensjö, E., Lemming, E., Michaëlsson, K., Vessby, B. (2014) Cancer death is related to high palmitoleic acid in serum and to polymorphisms in the SCD-1 gene in healthy Swedish men. Am. J. Clin. Nutr. 99, 551-558. <https://doi.org/10.3945/ajcn.113.065714>
8. Chan, D. C., Wong, A. T., Yamashita, S., Wats, G. F. (2012) Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment. Atherosclerosis 221, 484-489. <https://doi.org/10.1016/j.atherosclerosis.2012.01.029>
9. Das, U. N. (2010) Metabolic Syndrome Pathophysiology. The Role of Essential Fatty Acids. Willey-Blackwell, Iowa.
10. Diffenderfer, M. R., Schaefer, E. J. (2014) The composition and metabolism of large and small LDL. Curr. Opin. Lipidol. 25, 221-226. <https://doi.org/10.1097/MOL.0000000000000067>
11. Durnin, J. V., Womersley, J. (1974) Body fat assessed from the total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 71 years. Br. J. Nutr. 32, 77-97. <https://doi.org/10.1079/BJN19740060>
12. Esterbauer, H., Gebicki, J., Puhl, H., Jürgens, G. (1992) The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13, 341-390. <https://doi.org/10.1016/0891-5849(92)90181-F>
13. Fazio, S., Linton, M. F. (2015) Regulation and clearance of apolipoprotein B-containing lipoproteins. In: Clinical Lipidology. A Companion to Braunwald´s Heart Disease, 2nd Edition, ed. Ballantyne, C. M., pp. 11-24, Elsevier, Philadelphia.
14. Gazi, I. F., Filippatos, T. D., Tsimihodimos, V., Saougos, V. G., Liberopoulos, E. N., Mikhailidis, D. P., Tselepis, A. D., Elisaf, M. (2006) The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol. Lipids 41, 647-654. <https://doi.org/10.1007/s11745-006-5015-8>
15. Gong, J., Campos, H., McGarvey, S., Wu, Z., Goldberg, R., Baylin, A. (2011) Genetic variation in stearoyl-CoA desaturase 1 is associated with metabolic syndrome prevalence in Costa Rican adults. J. Nutr. 141, 2211-2218. <https://doi.org/10.3945/jn.111.143503>
16. Hayashi, T., Hirano, T., Taira, T., Tokuno, A., Mori, Y., Koba, S., Adachi, M. (2008) Remarkable increase of apolipoprotein B48 level in diabetic patients with end-stage renal disease. Atherosclerosis 197, 154-158. <https://doi.org/10.1016/j.atherosclerosis.2007.03.015>
17. Jáchymová, M., Horký, K., Bultas, J., Kozich, V., Jindra, A., Peleska, J., Martásek, P. (2001) Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem. Biophys. Res. Commun. 284, 426-430. <https://doi.org/10.1006/bbrc.2001.5007>
18. Jacobs, S., Schiller, K., Jansen, E., Fritsche, A., Weikert, C., di Giuseppe, R., Boeing, H., Schulze, M. B., Kröger, J. (2015) Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study. Eur. J. Clin. Nutr. 69, 642-646. <https://doi.org/10.1038/ejcn.2015.36>
19. Kawashima, A., Sugawara, S., Okita, M., Akahane, T., Fukui, K., Hashiuchi, M., Kataoka, C., Tsukamoto, I. (2009) Plasma fatty acid composition, estimated desaturase activities, and intakes of energy and nutrient in Japanese men with abdominal obesity or metabolic syndrome. J. Nutr. Sci. Vitaminol. (Tokyo) 55, 400-406. <https://doi.org/10.3177/jnsv.55.400>
20. Kamal, S., Saleem, A., Rehman, S., Bibi, I., Iqbal, H. M. N. (2018) Protein engineering: Regulatory perspectives of stearoyl CoA desaturase. Int. J. Biol. Macromol. 114, 692-699. <https://doi.org/10.1016/j.ijbiomac.2018.03.171>
21. Kinoshita, M., Ohnishi, H., Maeda, T., Yoshimura, N., Takeoka, Y., Yasuda, D., Kusano, J., Mashimo, Y., Saito, S., Shimamoto, K., Teramoto, T. (2009) Increased serum apolipoprotein B48 concentration in patients with metabolic syndrome. J. Atheroscler. Thromb. 16, 517-522. <https://doi.org/10.5551/jat.No604>
22. Koeberle, A., Löser, K., Thürmer, M. (2016) Stearoyl-CoA desaturase-1 and adaptive signaling. Biochim. Biophys. Acta 1861, 1719-1726. <https://doi.org/10.1016/j.bbalip.2016.08.009>
23. Kröger, J., Schulze, M. B. (2012) Recent insight into the relation of Δ5 desaturase and Δ6 desaturase activity to the development of type 2 diabetes. Curr. Opin. Lipidol. 23, 4-10. <https://doi.org/10.1097/MOL.0b013e32834d2dc5>
24. Lapice, E., Cipriano, P., Patti, L., Romano, G., Vaccaro, O., Rivellese, A. A. (2012) Fasting apolipoprotein B48 is associated with asymptomatic peripheral arterial disease in type 2 diabetic subjects: a case-control study. Atherosclerosis 223, 504-506. <https://doi.org/10.1016/j.atherosclerosis.2012.05.038>
25. Liew, C. F., Groves, C. J., Wiltshire, S., Zeggini, E., Frayling, T. M., Owen, K. R., Walker, M., Hitman, G. A., Levy, J. C., O’Rahilly, S., Hattersley, A. T., Johnston, D. G., McCarthy, M. I. (2004) Analysis of the contribution to type 2 diabetes susceptibility of sequence variation in the gene encoding stearoyl-CoA desaturase, a key regulator of lipid and carbohydrate metabolism. Diabetologia 47, 2168-2175. <https://doi.org/10.1007/s00125-004-1575-4>
26. Lohman, T. G., Roche, A. F., Martorell, R. (1988) Anthropometric Standardization Reference Manual. Human Kinetics Books, Champaign, IL.
27. Mahendran, Y., Agren, J., Uusitupa, M., Cederberg, H., Vangipurapu, J., Stančáková, A., Schwab U., Kuusisto J., Laakso M. (2014) Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. Am. J. Clin. Nutr. 99, 79-85. <https://doi.org/10.3945/ajcn.113.069740>
28. Mancera-Romero, J., Sánchez-Caparro, M. A., Rioja, J., Ariza, M. J., Olivecrona, G., González-Santos, P., Valdivielso, P. (2013) Fasting apolipoprotein B48 is a marker for peripheral arterial disease in type 2 diabetes. Acta Diabetol. 50, 383-389. <https://doi.org/10.1007/s00592-012-0434-x>
29. Martin-Núñez, G. M., Cabrera-Mulero, R., Rojo-Martínez, G., Gómez-Zumaquero, J. M., Chaves, F. J., de Marco, G., Soriguer, F., Castaño, L., Morcillo, S. (2013) Polymorphisms in the SCD1 gene are associated with indices of stearoyl CoA desaturase activity and obesity: a prospective study. Mol. Nutr. Food Res. 57, 2177-2184. <https://doi.org/10.1002/mnfr.201300208>
30. Masuda, D., Sugimoto, T., Tsujii, K.-I., Inagaki, M., Nakatani, K., Yuasa-Kawase, M., Tsubakio-Yamamoto, K., Ohama, T., Nishida, M., Ishigami, M., Kawamoto, T., Matsuyama, A., Sakai, N., Komuro, I., Yamashita, S. (2012) Correlation of fasting serum apolipoprotein B-48 with coronary artery disease prevalence. Eur. J. Clin. Invest. 42, 992-999. <https://doi.org/10.1111/j.1365-2362.2012.02687.x>
31. Masuda, D., Nishida, M., Arai, T., Hanada, H., Yoshida, H., Yamauchi-Takihara, K., Moriyama, T., Tada, N., Yamashita, S. (2014) Reference interval for the apolipoprotein B-48 concentration in healthy Japanese individuals. J. Atheroscler. Thromb. 21, 618-627. <https://doi.org/10.5551/jat.22558>
32. Masuda, D., Yamashita, S. (2017) Postprandial hyperlipidemia and remnant lipoproteins. J. Atheroscler. Thromb. 24, 95-109. <https://doi.org/10.5551/jat.RV16003>
33. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419. <https://doi.org/10.1007/BF00280883>
34. Mauvoisin, D., Mounier, C. (2011) Hormonal and nutritional regulation of SCD1 gene expression. Biochimie 93, 78-86. <https://doi.org/10.1016/j.biochi.2010.08.001>
35. Merino, D. M., Ma, D. W., Mutch, D. M. (2010) Genetic variation in lipid desaturases and its impact on the development of human disease. Lipids Health Dis. 9, 63. <https://doi.org/10.1186/1476-511X-9-63>
36. Merino, D. M., Johnston, H., Clarke, S., Roke, K., Nielsen, D., Badawi, A., El-Sohemy, A., Ma, D. W., Mutch, D. M. (2011) Polymorphisms in FADS1 and FADS2 alter desaturase activity in young Caucasian and Asian adults. Mol. Genet. Metab. 103, 171-178. <https://doi.org/10.1016/j.ymgme.2011.02.012>
37. Miller, S. A., Dykes, D. D., Polesky, H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215. <https://doi.org/10.1093/nar/16.3.1215>
38. Mori, K., Ishida, T., Yasuda, T., Monguchi, T., Sasaki, M., Kondo, K., Hasokawa, M., Nakajima, H., Haraguchi., Y, Sun, L., Shinohara, M., Toh, R., Nishimura, K., Hirata, K.- I. (2013) Fasting serum concentration of apolipoprotein B48 represents residual risks in patients with new-onset and chronic coronary artery disease. Clin. Chim. Acta 421, 51-56. <https://doi.org/10.1016/j.cca.2013.02.005>
39. Nakajima, K., Nakano, T., Tanaka, A. (2006) The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clin. Chim. Acta 367, 36-47. <https://doi.org/10.1016/j.cca.2005.12.013>
40. Nakajima, K., Tanaka, A. (2018) Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis. Clin. Chim. Acta 478, 200-215. <https://doi.org/10.1016/j.cca.2017.12.039>
41. Ng, D. S. (2013) Diabetic dyslipidemia: from evolving pathophysiological insight to emerging therapeutic targets. Can. J. Diabetes 37, 319-326. <https://doi.org/10.1016/j.jcjd.2013.07.062>
42. Okubo, M., Hanada, H., Matsui, M., Hidaka, Y., Masuda, D., Sakata, Y., Yamashita, S. (2014) Serum apolipoprotein B-48 concentration is associated with a reduced estimated glomerular filtration rate and increased proteinuria. J. Atheroscler. Thromb. 21, 974-982. <https://doi.org/10.5551/jat.23309>
43. Otokozawa, S., Ai, M., Diffenderfer, M. R., Asztalos, B. F., Tanaka, A., Lamon-Fava, S., Schaefer, E. J. (2009) Fasting and postprandial apolipoprotein B-48 levels in healthy, obese and hyperlipidemic subjects. Metabolism 58, 1536-1542. <https://doi.org/10.1016/j.metabol.2009.04.040>
44. Paton, C. M., Ntambi, J. M. (2009) Biochemical and physiological function of stearoyl-CoA desaturase. Am. J. Physiol. Endocrinol. Metab. 297, E28-E37. <https://doi.org/10.1152/ajpendo.90897.2008>
45. Poloni, S., Blom, H. J., Schwartzs, I. V. (2015) Stearoyl-CoA desaturase-1: is it the link between sulphur amino acids and lipid metabolism? Biology (Basel) 4, 383-396.
46. Rudkowska, I., Julien, P., Couture, P., Lemieux, S., Tchernof, A., Barbier, O., Vohl, M. C. (2014) Cardiometabolic risk factors are influenced by stearoyl-CoA desaturase (SCD)-1 gene polymorphisms and n-3 polyunsaturated fatty acid supplementation. Mol. Nutr. Food Res. 58, 1079-1086. <https://doi.org/10.1002/mnfr.201300426>
47. Saito, E., Okada, T., Abe, Y., Odaka, M., Kuromori, Y., Iwata, F., Hara, M., Mugishima, H., Kitamura, Y. (2013) Abdominal adiposity is associated with fatty acid desaturase activity in boys: implications for C-reactive protein and insulin resistance. Prostaglandins Leukot. Essent. Fatty Acids 88, 307-311. <https://doi.org/10.1016/j.plefa.2013.01.005>
48. Sakai, N., Uchida, Y., Ohashi, K., Hibuse, T., Saika, Y., Tomari, Y., Kihara S, Hiraoka H, Nakamura T, Ito S, Yamashita S, Matsuzawa Y. (2003) Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA. J. Lipid Res. 44, 1256-1262. <https://doi.org/10.1194/jlr.M300090-JLR200>
49. Sanger, F., Coulson, A. R. (1975) A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J. Mol. Biol. 94, 441-448. <https://doi.org/10.1016/0022-2836(75)90213-2>
50. Sanger, F., Nicklen, S., Coulson, A. R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467. <https://doi.org/10.1073/pnas.74.12.5463>
51. Saponaro, C., Gaggini, M., Carli, F., Gastaldelli, A. (2015) The subtle balance between lipolysis and lipogenesis. A critical point in metabolic homeostasis. Nutrients 7, 9453-9474. <https://doi.org/10.3390/nu7115475>
52. Sato, I., Ishikawa, Y., Ishimoto, A., Katsura, S., Toyokawa, A., Hayashi, F., Kawano, S., Fujioka, Y., Yamashita, S., Kumagai, S. (2009) Significance of measuring serum concentrations of remnant lipoproteins and apolipoprotein B-48 in fasting period. J. Atheroscl. Thromb. 16, 12-20. <https://doi.org/10.5551/jat.E596>
53. Stryjecki, C., Roke, K., Clarke, S., Nielsen, D., Badawi, A., El-Sohemy, A., Ma, D. W., Mutch, D. M. (2012) Enzymatic activity and genetic variation in SCD1 modulate the relationship between fatty acids and inflammation. Mol. Genet. Metab. 105, 421-427. <https://doi.org/10.1016/j.ymgme.2011.12.003>
54. Tan, C. Y., Virtue, S., Murfitt, S., Robert, L. D., Phua, Y. H., Dale, M., Griffin, J. L., Tinahones, F., Scherer, P. E., Vidal- Puig, A. (2015) Adipose tissue fatty acid chain length and non-unsaturation increases with obesity and insulin resistance. Sci. Rep. 5, 18366. <https://doi.org/10.1038/srep18366>
55. Tanimura, K., Nakajima, Y., Nagao, M., Ishizaki, A., Kano, T., Harada, T., Okajima, F., Sudo, M., Tamura, H., Ishii, S., Sugihara, H., Yamashita, S., Asai, A., Oikawa, S. (2008) Association of serum apolipoprotein B48 level with the presence of carotid plaque in type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 81, 338-344. <https://doi.org/10.1016/j.diabres.2008.04.028>
56. Tosi, F., Sartori, F., Guarini, P., Olivieri, O., Martinelli, N. (2014) Delta-5 and delta-6 desaturases: crucial enzymes in polyunsaturated fatty acid-related pathways with pleiotropic influences in health and disease. Adv. Exp. Med. Biol. 824, 61-81. <https://doi.org/10.1007/978-3-319-07320-0_7>
57. Tvrzicka, E., Vecka, M., Stankova, B., Zak, A. (2002) Analysis of fatty acids in plasma lipoproteins by gas chromatography-flame ionisation detection. Quantitative aspects. Anal. Chim. Acta 465, 337-350. <https://doi.org/10.1016/S0003-2670(02)00396-3>
58. Uto, Y. (2016) Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors. Chem. Phys. Lipids 197, 3-12. <https://doi.org/10.1016/j.chemphyslip.2015.08.018>
59. Valdivielso, P., Puerta, S., Rioja, J., Alonso, I., Ariza, M. J., Sánchez-Chaparro, M. A., Palacios, R., González-Santos, P. (2010) Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: a study in patients with type 2 diabetes and controls. Clin. Chim. Acta 411, 433-437. <https://doi.org/10.1016/j.cca.2009.12.022>
60. Vareka, T., Vecka, M., Jirak, R., Tvrzicka, E., Macasek, J., Zak, A., Zeman, M. (2012) Plasma fatty acid profile in depressive disorder resembles insulin resistance state. Neuro Endocrinol. Lett. 33(Suppl. 2), 83-86.
61. Wang, Y., Pendlebury, C., Dodd, M. M., Maximova, K., Vine, D. F., Jetha, M. M., Ball, G. D., Proctor, S. D. (2013) Elevated remnant lipoproteins may increase subclinical CVD risk in pre-pubertal children with obesity: a case-control study. Pediatr. Obes. 8, 376-384. <https://doi.org/10.1111/j.2047-6310.2012.00116.x>
62. Warensjö, E., Ohrvall, M., Vessby, B. (2006) Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr. Metab. Cardiovasc. Dis. 16, 128-136. <https://doi.org/10.1016/j.numecd.2005.06.001>
63. Warensjö, E., Ingelsson, E., Lundmark, P., Lannfelt, L., Syvänen, A. C., Vessby, B., Risérus, U. (2007) Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity. Obesity (Silver Spring) 15, 1732-1740. <https://doi.org/10.1038/oby.2007.206>
64. Warensjö, E., Risérus, U., Gustafsson, I. B., Mohsen, R., Cederholm, T., Vessby, B. (2008) Effects of saturated and unsaturated fatty acids on estimated desaturase activities during a controlled dietary intervention. Nutr. Metab. Cardiovasc. Dis. 18, 683-690. <https://doi.org/10.1016/j.numecd.2007.11.002>
65. Zak, A., Tvrzická, E., Vecka, M., Jachymová, M., Duffková, L., Stanková, B., Vavrova, L., Kodydkova, J., Zeman, M. (2007) Severity of metabolic syndrome unfavorably influences oxidative stress and fatty acid metabolism in men. Tohoku J. Exp. Med. 212, 359-371. <https://doi.org/10.1620/tjem.212.359>
66. Zak, A., Burda, M., Vecka, M., Zeman, M., Tvrzicka, E., Stanková, B. (2014) Fatty acid composition indicates two types of metabolic syndrome independent of clinical and laboratory parameters. Physiol. Res. 63(Suppl. 3), S375-S385. <https://doi.org/10.33549/physiolres.932868>
67. Zeman, M., Vecka, M., Burda, M., Tvrzicka, E., Stanková, B., Macasek, J., Zak, A. (2017) Fatty acid composition of plasma phosphatidylcholine determines body fat parameters in subjects with metabolic syndrome-related traits. Metab. Syndr. Relat. Disord. 15,
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive